您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > (±)-Verapamil-d3(hydrochloride)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
(±)-Verapamil-d3(hydrochloride)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
(±)-Verapamil-d3(hydrochloride)图片
规格:98%
分子量:494.1
包装与价格:
包装价格(元)
500ug电议
1mg电议
5mg电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx20890
CAS:N/A
分子式:C27H35D3N2O4.HCl
分子量:494.1
溶解度:DMF: 15 mg/mL,DMSO: 10 mg/mL,Ethanol: 10 mg/mL,PBS (pH 7.2): 0.25 mg/mL
纯度:98%
存储:Store at -20°C
库存:现货

Background:

(±)-Verapamil-d3(hydrochloride) is intended for use as an internal standard for the quantification of verapamil by GC- or LC-MS. Verapamil is the prototypical blocker of L-type calcium channels that produces excitation-contraction uncoupling in cardiac muscle by preventing the slow-inward current of calcium ions.1Verapamil can also block calcium fluxes in vascular smooth muscle. It has both peripheral and coronary vasodilator effects (IC50= 0.38 μM in guinea pig aortic strip) and has been used to control hypertension, angina, cardiac arrhythmia, and vascular headaches.2,3,4Verapamil has also been used in cell biology as an inhibitor of drug efflux pump proteins such as P-glycoprotein, which are often over-expressed in certain tumor cell lines.5


1.Singh, B.N.The mechanism of action of calcium antagonists relative to their clinical applicationsBr. J. Clin. Pharmacol.21109S-121S(1986) 2.Dei, S., Romanelli, M.N., Scapecchi, S., et al.Verapamil analogues with restricted molecular flexibility: Synthesis and pharmacological evaluation of the four isomers of α-[1-[3-[N-[1-[2-(3,4-dimethoxy-phenyl)ethyl]]-N-methylamino]cyclohexyl]]-α-isopropyl-3,4-dimethoxybenzene-acetonitrileJournal of Medicinal Chemistry36439-445(1993) 3.Dawson, J.R., Whitaker, N.H.G., and Sutton, G.C.Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipineBritish Heart Journal46508-512(2013) 4.Campbell, T.J., and Williams, K.M.Therapeutic drug monitoring: Antiarrhythmic drugsBr. J. Clin. Pharmacol.52307-319(1998) 5.Rabindran, S.K., He, H., Singh, M., et al.Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin CCancer Res.58(24)5850-5858(1998)